A similar CXCR7 over-expression has been described in a variety of cancers, with particular implication for cancer initiation, progression and metastasis [47,48,49,50,51,52,53], mainly mediated via ERK activation [54,55]. This evidence concerns the gene ACKR3 and cancer.